X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
c-phycocyanin (129) 129
index medicus (125) 125
animals (100) 100
phycocyanin (86) 86
oxidative stress (78) 78
male (68) 68
rats (68) 68
spirulina (63) 63
humans (60) 60
antioxidant (54) 54
antioxidants (48) 48
mice (47) 47
phycocyanin - pharmacology (46) 46
inflammation (40) 40
spirulina platensis (38) 38
cyanobacteria (36) 36
spirulina - chemistry (35) 35
phycocyanin - administration & dosage (34) 34
spirulina-platensis (34) 34
female (33) 33
pharmacology & pharmacy (32) 32
apoptosis (31) 31
nutrition & dietetics (31) 31
biochemistry & molecular biology (29) 29
in-vitro (29) 29
rodents (27) 27
oxidative stress - drug effects (26) 26
dietary supplements (25) 25
algae (24) 24
platensis (24) 24
research (24) 24
antioxidants - pharmacology (23) 23
food science & technology (23) 23
phycocyanin - chemistry (20) 20
proteins (20) 20
chemistry, medicinal (19) 19
lipid-peroxidation (19) 19
lipids (19) 19
rats, wistar (19) 19
research article (19) 19
toxicity (19) 19
apoptosis - drug effects (18) 18
article (18) 18
analysis (17) 17
biotechnology & applied microbiology (17) 17
cell biology (17) 17
enzymes (17) 17
gene expression (17) 17
lipid peroxidation (17) 17
liver (17) 17
medicine (17) 17
rats, sprague-dawley (17) 17
antioxidant activity (16) 16
cell proliferation - drug effects (16) 16
chlorophyll (16) 16
damage (16) 16
expression (16) 16
liver - drug effects (16) 16
physiological aspects (16) 16
cell survival - drug effects (15) 15
environmental sciences (15) 15
antioxidants - administration & dosage (14) 14
cancer (14) 14
cholesterol (14) 14
diet (14) 14
dose-response relationship, drug (14) 14
fluorescence (14) 14
health aspects (14) 14
liver - metabolism (14) 14
medicine, research & experimental (14) 14
purification (14) 14
science (14) 14
glutathione (13) 13
inhibition (13) 13
phycocyanin - isolation & purification (13) 13
phycocyanin - metabolism (13) 13
prevention (13) 13
remote sensing (13) 13
usage (13) 13
antiinflammatory activity (12) 12
disease models, animal (12) 12
free radicals (12) 12
multidisciplinary sciences (12) 12
phycocyanobilin (12) 12
antioxidants - metabolism (11) 11
biology (11) 11
care and treatment (11) 11
extract (11) 11
lipid peroxidation - drug effects (11) 11
oncology (11) 11
phycocyanin - therapeutic use (11) 11
pigments (11) 11
reactive oxygen species - metabolism (11) 11
activation (10) 10
administration, oral (10) 10
cells (10) 10
chemistry (10) 10
cytotoxicity (10) 10
food (10) 10
glutathione - metabolism (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 02/2018, Volume 194, pp. 130 - 138
Journal Article
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 2, pp. 110 - 120
We and other investigators have reported that bilirubin and its precursor biliverdin may have beneficial effects on diabetic vascular complications, including... 
Phycobilin | Albuminuria | Bilirubin | Nad(P)h oxidase | Superoxide production | superoxide production | ACTIVATION | PHYSIOLOGY | C-PHYCOCYANIN | RATS | NAD(P)H oxidase | albuminuria | VASCULAR COMPLICATIONS | HEART-DISEASE | bilirubin | phycobilin | KIDNEY | EXPRESSION | CORONARY-ARTERY-DISEASE | SERUM BILIRUBIN | Kidney - pathology | Diabetic Nephropathies - etiology | Phycobilins - administration & dosage | Humans | NADPH Oxidases - metabolism | Male | Diabetes Mellitus, Type 2 - metabolism | Bilirubin - pharmacology | Biliverdine - pharmacology | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Time Factors | Phycobilins - pharmacology | Superoxides - metabolism | Albuminuria - metabolism | Phycocyanin - pharmacology | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Disease Models, Animal | Phycocyanin - administration & dosage | Phycobilins - isolation & purification | Diabetic Nephropathies - pathology | Kidney - drug effects | Albuminuria - etiology | Administration, Oral | Spirulina - chemistry | Diabetic Nephropathies - metabolism | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Diabetic Nephropathies - genetics | Antioxidants - pharmacology | Phycocyanin - isolation & purification | Albuminuria - prevention & control | Fibronectins - metabolism | Animals | Antioxidants - isolation & purification | Antioxidants - administration & dosage | Mice | Oxidative Stress - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Transforming Growth Factor beta - metabolism | Prevention | Oxidative stress | Spirulina | Phytochemistry | Diabetic nephropathies | Physiological aspects | Research | Health aspects
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 2/2012, Volume 361, Issue 1, pp. 217 - 228
Cancer research illustrated that combinatorial studies can provide significant improvement in safety and effectiveness over the monotherapy regimens. A... 
Life Sciences | Biochemistry, general | Piroxicam | COX-2 | PGE 2 | Medical Biochemistry | Oncology | C-phycocyanin | Cardiology | Apoptosis | CYCLOOXYGENASE-2 | NONSTEROIDAL ANTIINFLAMMATORY DRUG | CELECOXIB | PGE | CELL BIOLOGY | CARCINOGENESIS | INFLAMMATION | GROWTH | INHIBITOR | COLONOCYTES | ABERRANT CRYPT FOCI | Intestinal Mucosa - metabolism | Apoptosis - drug effects | Colon - drug effects | Male | Cyclooxygenase 2 - genetics | DNA Fragmentation | Carcinoma - pathology | Drug Therapy, Combination | Colorectal Neoplasms - metabolism | Anticarcinogenic Agents - therapeutic use | Edema - prevention & control | Cyclooxygenase 1 - genetics | Gene Expression | Phycocyanin - therapeutic use | Colon - pathology | Colorectal Neoplasms - prevention & control | Piroxicam - therapeutic use | Rats | Carcinoma - chemically induced | Carcinoma - prevention & control | 1,2-Dimethylhydrazine | Colorectal Neoplasms - chemically induced | Rats, Sprague-Dawley | Colon - metabolism | Dinoprostone - metabolism | Animals | Cyclooxygenase 2 - metabolism | Carcinoma - metabolism | Carrageenan | Cyclooxygenase 1 - metabolism | Edema - chemically induced | Colorectal Neoplasms - pathology | Intestinal Mucosa - pathology | Prevention | Immunohistochemistry | Enzymes | Colon cancer | Carrageenin | Fluocinolone acetonide | DNA | Cancer | Chemotherapy | Cellular biology | Rodents | Genomics | Colorectal cancer | Pharmacology | Index Medicus
Journal Article
Journal Article
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 09/2017, Volume 12, pp. 6537 - 6558
Background: Cisplatin (Cis) is a widely used chemotherapeutic drug for treating a variety of cancers, due to its ability to induce cell death in cancer cells... 
Oxidative stress | Cell viability | Graphene oxide-silver nanoparticles nanocomposites | Autophagy | Cisplatin | Apoptosis | autophagy | apoptosis | NANOSCIENCE & NANOTECHNOLOGY | DEATH | OVARIAN-CANCER | SHEETS | cell viability | THERAPY | HELA-CELLS | REDUCTION | graphene oxide-silver nanoparticles nanocomposites | GREEN SYNTHESIS | RESISTANCE | PHARMACOLOGY & PHARMACY | cisplatin | CYTOTOXICITY | oxidative stress | Cell Survival - drug effects | Silver - pharmacology | Reactive Oxygen Species - metabolism | Nanocomposites - chemistry | Antineoplastic Combined Chemotherapy Protocols - chemistry | Apoptosis - drug effects | Humans | Metal Nanoparticles - chemistry | Oxides - chemistry | Silver - chemistry | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Cisplatin - pharmacology | Autophagy - drug effects | Antineoplastic Combined Chemotherapy Protocols - chemical synthesis | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Cisplatin - administration & dosage | Phycocyanin - chemistry | Silver - administration & dosage | Autophagosomes - drug effects | Metal Nanoparticles - administration & dosage | Cell Line, Tumor | Female | Graphite - chemistry | Autophagy (Cytology) | Usage | Care and treatment | Innovations | Nanoparticles | Silver | Graphene | Dosage and administration | Health aspects | Cervical cancer | Methods | Cancer | Lung cancer | Gynecology | Cytotoxicity | Nanomaterials | Breast cancer | Radiation therapy | Drug resistance | Cancer therapies | Ovarian cancer | Chemotherapy | Nanocomposites | Womens health | Surgery | Cell cycle | Tumorigenesis
Journal Article
Journal Article
Journal Article
Phytomedicine, ISSN 0944-7113, 2007, Volume 14, Issue 11, pp. 739 - 746
Journal Article
Scientific Reports, ISSN 2045-2322, 09/2015, Volume 5, Issue 1, p. 14418
Journal Article
Journal Article